- Home
- ACRV vs JAKK Comparison
ACRV vs JAKK Comparison
Compare ACRV & JAKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- JAKK
- Stock Information
- Founded
- ACRV 2018
- JAKK 1995
- Country
- ACRV United States
- JAKK United States
- Employees
- ACRV N/A
- JAKK N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- JAKK Recreational Games/Products/Toys
- Sector
- ACRV Health Care
- JAKK Consumer Discretionary
- Exchange
- ACRV Nasdaq
- JAKK Nasdaq
- Market Cap
- ACRV 247.8M
- JAKK 200.6M
- IPO Year
- ACRV 2022
- JAKK 1996
- Fundamental
- Price
- ACRV $7.93
- JAKK $28.53
- Analyst Decision
- ACRV Strong Buy
- JAKK Strong Buy
- Analyst Count
- ACRV 5
- JAKK 4
- Target Price
- ACRV $22.60
- JAKK $41.25
- AVG Volume (30 Days)
- ACRV 44.0K
- JAKK 116.2K
- Earning Date
- ACRV 11-13-2024
- JAKK 10-30-2024
- Dividend Yield
- ACRV N/A
- JAKK N/A
- EPS Growth
- ACRV N/A
- JAKK N/A
- EPS
- ACRV N/A
- JAKK 2.99
- Revenue
- ACRV N/A
- JAKK $687,697,000.00
- Revenue This Year
- ACRV N/A
- JAKK N/A
- Revenue Next Year
- ACRV N/A
- JAKK $3.56
- P/E Ratio
- ACRV N/A
- JAKK $9.54
- Revenue Growth
- ACRV N/A
- JAKK N/A
- 52 Week Low
- ACRV $3.19
- JAKK $17.06
- 52 Week High
- ACRV $11.90
- JAKK $36.84
- Technical
- Relative Strength Index (RSI)
- ACRV 48.40
- JAKK 53.34
- Support Level
- ACRV $7.69
- JAKK $27.82
- Resistance Level
- ACRV $8.66
- JAKK $30.83
- Average True Range (ATR)
- ACRV 0.34
- JAKK 1.33
- MACD
- ACRV -0.00
- JAKK -0.04
- Stochastic Oscillator
- ACRV 22.64
- JAKK 42.50
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-brand toy company that designs, produces, markets, and distributes toys and related products, consumables, and related products, electronics and related products, kids' indoor and outdoor furniture, and other consumer products. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others.